Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Sep 23, 2026
D-Wave Quantum (QBTS) vs Quantum Computing (QUBT): Weighing Two Quantum Computing Approaches

D-Wave Quantum (QBTS) vs Quantum Computing (QUBT): Weighing Two Quantum Computing Approaches

Key Takeaways

  • Different technologies: QBTS centers on superconducting quantum annealing plus a new gate-model effort, while QUBT emphasizes photonics, advanced packaging, and quantum optimization hardware.
  • Scale versus diversification: QBTS offers a more established, commercialized platform, whereas QUBT is building a broader portfolio across quantum, photonics, and semiconductor manufacturing.
  • Valuation gap: Both trade at elevated price-to-sales multiples, but QBTS carries a meaningfully higher forward valuation than QUBT.
  • Analyst sentiment differs: QBTS holds a "Strong Buy" consensus, while QUBT carries a more measured "Moderate Buy" rating.
  • Cash positions diverge: QUBT holds roughly $1.3 billion in cash and investments, a larger liquidity cushion than QBTS.
  • Both are unprofitable: Neither company has reached profitability, and rising operating expenses remain a shared risk factor.

Setting the Stage for These Quantum Plays

D-Wave Quantum (QBTS) and Quantum Computing (QUBT) stand out as two of the more prominent pure-play names in the developing quantum-computing space. Although they share the same broad industry, their technical paths and business models differ enough to drive distinct market reactions. This comparison matters most for growth-focused investors looking to gain exposure to quantum technology while considering differences in commercialization progress, revenue scale, liquidity, and valuation. From what I see, understanding how each company performs relative to the other can clarify which profile better matches an individual investor’s risk tolerance and time frame.

QBTS: Focus on Superconducting Annealing

D-Wave Quantum specializes in superconducting quantum-computing systems, primarily its quantum annealing platforms aimed at solving complex optimization challenges. The company has also started developing a complementary gate-model platform, partly through its acquisition of Quantum Circuits. Recently, QBTS secured an agreement with the U.S. Department of Commerce for access to as much as $100 million under the CHIPS and Science Act. Management has pointed to stronger commercial momentum, including additional deployments with telecommunications partners. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Even with these developments, the shares have come under pressure, falling about 60% from their 52-week high. Latest quarterly revenue held roughly flat year over year near $3.1 million, although bookings increased. Analysts maintain a generally positive stance, reflected in a "Strong Buy" consensus and an average price target notably above current levels. Still, the elevated cash burn and a forward price-to-sales ratio well above typical industry benchmarks stand out as important considerations.

QUBT: Photonics and Diversification Strategy

Quantum Computing, known as QCi, focuses on quantum and photonics technologies, products, and services. Its offerings cover quantum optimization systems, photonic computing, quantum communications, and advanced semiconductor packaging, a wider approach supported by recent acquisitions such as NHanced Semiconductors. In recent activity, QUBT has seen interest tied to commercial deployments, including placement of its Dirac-3 system at a global consulting firm and a new framework agreement with Qatar’s Hamad Bin Khalifa University covering quantum computing, sensing, and communications.

Financially, the latest quarter showed a sharp year-over-year revenue jump from a very small base to approximately $5.6 million, backed by a contract backlog near $42.5 million. The company also maintains about $1.3 billion in cash and investments. That said, the stock has fallen significantly over the past year, profitability is still absent, operating expenses have risen quickly, and the most recent quarter posted a gross loss.

Side-by-Side Analysis

The most obvious distinction lies in technical approach and business emphasis. QBTS represents a more focused quantum-computing play built around annealing systems and a newer gate-model direction, supported by an established base of more than 100 revenue-generating customers. QUBT, in contrast, follows a broader model that reaches into photonics and semiconductor manufacturing, placing it across neighboring high-growth areas such as AI, defense, and telecommunications.

Financial structures also differ. QUBT’s larger cash position offers a stronger liquidity buffer, while QBTS combines cash, government funding, and customer bookings to support operations. On valuation, QBTS trades at a higher forward price-to-sales multiple than QUBT, which aligns with firmer analyst conviction but also leaves less margin for execution shortfalls. Risk profiles vary too: QBTS contends with cash burn and potential dilution questions, whereas QUBT needs to show it can turn rising revenue and acquisitions into sustainable gross margins and profitability. Market sentiment has remained volatile for both, with each stock experiencing sharp pullbacks from earlier highs despite ongoing business advances.

AI-Assisted Perspective on the Pair

Looking at observable factors such as trend consistency, analyst positioning, and commercial momentum, Tickeron’s AI would likely lean toward QBTS at this point. The stock’s "Strong Buy" consensus, greater analyst-implied upside, and more established commercialization route through quantum annealing point to relatively stronger positioning. The assessment remains probabilistic, however. QUBT’s diversified revenue streams and substantial cash holdings offer a credible alternative, especially for investors who prioritize liquidity and a wider technology portfolio. In the end, the better fit depends on whether an investor values momentum more than balance-sheet strength, and both names carry elevated risk given their early-stage path to profitability.

Leveraging Systematic AI Tools

In my own research process, I often reference Tickeron’s Trending AI Robots to review algorithmic strategies that can complement fundamental comparisons like this one. The section curates top-performing bots across different styles, time frames, and watchlists, highlighting metrics such as win rates and profit factors. It provides a practical way to explore systematic signals that align with individual objectives when evaluating names in emerging sectors.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: QUBT, QBTS

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


QUBT's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for QUBT turned positive on September 17, 2026. Looking at past instances where QUBT's MACD turned positive, the stock continued to rise in 41 of 45 cases over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 16, 2026. You may want to consider a long position or call options on QUBT as a result. In 66 of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 81%.

QUBT moved above its 50-day moving average on September 17, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +4.37% 3-day Advance, the price is estimated to grow further. Considering data from situations where QUBT advanced for three days, in 192 of 225 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where QUBT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.

QUBT broke above its upper Bollinger Band on September 17, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for QUBT entered a downward trend on September 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating fairly steady price growth. QUBT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.274) is normal, around the industry mean (7.364). P/E Ratio (0.000) is within average values for comparable stocks, (49.824). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (23.980). Dividend Yield (0.000) settles around the average of (0.004) among similar stocks. P/S Ratio (169.492) is also within normal values, averaging (51.774).

The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 92 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. QUBT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are Dell Technologies (NYSE:DELL), Arista Networks Inc (NYSE:ANET), Seagate Technology Holdings PLC (NASDAQ:STX), Western Digital Corp (NASDAQ:WDC), HP (NYSE:HPQ), 3D Systems Corp (NYSE:DDD).

Industry description

Computer Processing Hardware industry produces central processing unit, monitor, keyboard, computer data storage devices, and graphics card. Business activity and economic growth are potential drivers of this industry – if more businesses are growing or flourishing, so would their investments in computer equipment. Dell Technologies, Inc, Hewlett Packard Enterprise Co., NCR Corporation are key producers of computer processing hardware.

Market Cap

The average market capitalization across the Computer Processing Hardware Industry is 32.09B. The market cap for tickers in the group ranges from -0.18 to 365.79B. DELL holds the highest valuation in this group at 365.79B. The lowest valued company is HAUP at -0.18.

High and low price notable news

The average weekly price growth across all stocks in the Computer Processing Hardware Industry was 6%. For the same Industry, the average monthly price growth was -2%, and the average quarterly price growth was 47%. QCLS experienced the highest price growth at 102%, while XTND experienced the biggest fall at -11%.

Volume

The average weekly volume growth across all stocks in the Computer Processing Hardware Industry was 19%. For the same stocks of the Industry, the average monthly volume growth was -36% and the average quarterly volume growth was -49%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 67
Price Growth Rating: 55
SMR Rating: 79
Profit Risk Rating: 85
Seasonality Score: 13 (-100 ... +100)
View a ticker or compare two or three
QUBT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry ComputerProcessingHardware

Industry
N/A
Address
No.5 Marine View Plaza
Phone
+1 703 436-2121
Employees
77
Web
https://www.quantumcomputinginc.com
Interact to see
Advertisement
USAS fell over 10% today, trading around US$5.83 by early afternoon from a previous close of US$6.55 — a one‑day decline of roughly 11% — as more than 5.9 million shares changed hands. The stock had surged earlier in 2026, with some data showing a move from about US$1.11 in March 2025 to over US$7.30 in mid‑March 2026 — a gain of more than 500% — leaving it vulnerable to profit‑taking.
CENX fell about 8.9% today, dropping US$4.94 to US$50.40 by midday, after closing at US$55.34 yesterday; shares now sit roughly 15% below their 52‑week high of US$59.12 but remain far above the 12‑month low of US$13.05. Q4 2025 results showed net sales of US$633.7 million and adjusted net income of US$128.2 million (US$1.25 per share), with adjusted EBITDA of US$170.6 million — a big sequential improvement — but GAAP net income was just US$1.8 million (US$0.02 per share), underscoring earnings volatility.
CNL shares fell over 8% today, trading down from around C$22.90 toward the low‑C$21s, after recently setting a new 1‑year high at C$28.99 on March 2 and gaining more than 70% over the past 12 months.
SMCI shares are plunging approximately 26% in Friday premarket trading, extending sharp after-hours losses from Thursday's session close of $30.79. The primary catalyst is a federal indictment unsealed March 19, 2026, charging three individuals associated with Super Micro — including a company co-founder — with conspiring to illegally export billions of dollars in AI server technology to China.
PL shares are surging approximately 19% in premarket trading on March 20, 2026, building on an 8.67% gain during the regular session on March 19. The primary catalyst is a blowout Q4 fiscal year 2026 earnings report released after the close on March 19, with quarterly revenue of $86.8 million — an 11.55% beat against consensus expectations of $77.81 million.
Unusual Machines (UMAC) is trading down approximately -8.60% in premarket on March 20, 2026, extending losses from the prior session. The primary catalyst is a proposed public stock offering announced after the market close on March 19, 2026, raising dilution concerns among investors.
FDX surged approximately 7% in premarket trading on March 20, 2026, moving from the prior session close of $356.11 to around $381. The primary catalyst is a blowout fiscal Q3 2026 earnings report, with adjusted EPS of $5.25 — beating Wall Street's consensus estimate of $4.13 by more than 27%.
Kingsoft Cloud Holdings Limited (KC) shares plunged about 9% in the most recent session, extending a sharp pullback after a recent rally. The selloff reflects mounting concerns around profitability, with the company still loss-making and showing weak multi-year revenue growth.
BAK shares fell roughly 11% in the latest trading session, marking a sharp single-day drop for the Brazilian petrochemical producer The decline comes amid persistent concerns about high leverage, a weaker credit profile, and soft petrochemical margins in a challenging macro environment for chemicals​
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.
SEDG is indicated down roughly 9% in premarket trading, following a strong advance in the prior regular session. The pullback comes after shares rallied on optimism around new product launches and an analyst upgrade, leaving the stock vulnerable to profit-taking and volatility.
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.